{"name":"RECORDATI GROUP","slug":"recordati-group","ticker":"","exchange":"","domain":"recordati.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOcHhlN2duOGFuYlJVTy1OU2VxTjdQenpycjNMaVhvdjdDQVJGeVh0dUk1RHBjSlJVVmllV0U3UkNjUVdOR0xZMzlfN0dFOG5oTlhLNUkyaWZ5N0hkZlNwUnpfWkNzNjVoUi0xT3lUb2Vlak04UU52cWZVSklfanowZVVuZnhUblJ3NXdtY1dSWUwxZkE?oc=5","date":"2026-03-27","type":"pipeline","source":"Pharmaceutical Technology","summary":"Recordati sizes up €10.9bn CVC Capital acquisition offer - Pharmaceutical Technology","headline":"Recordati sizes up €10.9bn CVC Capital acquisition offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPUFRWU3BTQkRhODhZNHROTFFEdTBCZ3JYT1h0Z3ZZcnotbnhFQWNubGhSMEt6dGlWcmFYYUN2Zl9rR2pTWDRYSURUc0I1U0xDWElxSVVDT2JIcHBLemRmWjNGUUVNbFktS2ZxNG5UZHA0blJiYUE5ZkpHWWxYdmxDRExVTC1xaE9iT2d3MzdR?oc=5","date":"2026-03-27","type":"pipeline","source":"pharmaphorum","summary":"Recordati gets €10.9bn takeover bid from private equity firm - pharmaphorum","headline":"Recordati gets €10.9bn takeover bid from private equity firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZ3BnT09FUTNrQVJSSzJ2YXdPYkRUbGRWX0FoLXBZR3B3aGJxaUl2anlxU0NteWFYcTZPeEdpTjVjRXRjcW5PcC1GYWFzUlUwcHJzRHpuUmlLbFVZcDVHRmhPbklnV3pxMFYzLWN2ZHM0QTdzN0xaR2NrVVM1NjV2b3V2X21VaHFxbGhRVXZmeWRVelgyM2pWRDdrNG9sdEJwVDRDaTN2VV9wUQ?oc=5","date":"2026-03-27","type":"pipeline","source":"The Pharma Letter","summary":"Recordati confirms 10.9 billion euro takeover approach from CVC - The Pharma Letter","headline":"Recordati confirms 10.9 billion euro takeover approach from CVC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPOWJsUm9Sa292M0ZGWjRuUWQxYUxQUm1vcWNXTFR6NVBFVFVpLUk4ejMzZU9tbTN0cVNTRGZNMVg3VHE3WjJkWHB1NDl3c1BLZzh5N2FrdThFMHB4aTZWVDZNamFncktIVVRPRmQ0ai1jRVRYT3hsMVFUVUpESVJfMGpRVnpHRnBOdThXamwxY3dFaGFSSHdmUA?oc=5","date":"2026-03-26","type":"pipeline","source":"The MBS Group","summary":"CVC reportedly considering full takeover of Recordati - The MBS Group","headline":"CVC reportedly considering full takeover of Recordati","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNY0VCdmNaVXNtSzh5ZVRVUERUMDRlZGlYb3RsdU9zaUc0OGhhUjBWdVdDek1VclFTcXl3TXU5bzBtZHUxVUtQanVQS3pldTJKVjZma21HNUlwSmZNRkdhSk0yajM1Z21IS2FwY0tpcTl5cHJmSGVSR0dBajVXOXppYUtOTW5tVEIxWmQ1NVRrang1eTFFZWtfbWRxS1NOMDdQTEFLTEhQaWlVZC1ackRNa1RhS0wtXzVz?oc=5","date":"2026-02-20","type":"earnings","source":"Statista","summary":"Revenue of Italian pharmaceutical company Recordati in 2023, by product - Statista","headline":"Revenue of Italian pharmaceutical company Recordati in 2023, by product","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOZ1FOTGhmMHVvaFdSZnJQSXVyS2pIWFNBMHpWUURhNjFZUUNQNVdoUzNyMVlISk1GLUVxU0kxbkJUQ3RVWkVvSmZPb0pZcHNSRFFPVmpwMkdnSkQ0RGhhd25nLXJGQ1poc2hvV3dvYW1sR2hMTnhaaXlFdFY2YlF5eFNjeHZ2dDEwMkk5U0E4ZzdqR3o1R0JVSmcwNi05QWZMcUpJYmgzYnVYZ2ZzWmNMV193MTU1VlBsQVZXQU9DMWRlN2lGbjA4?oc=5","date":"2026-02-17","type":"deal","source":"Pharmafile","summary":"Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals - Pharmafile","headline":"Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQTE4xdVczM2VDbTJobDdnUzRIbnJFcEJJVXdlc3pCSmpGZ3Jta2dWckNNbmFWUS15aXFNWi1XanJ1Nm9yMVlKTjUzMkREN2gtY011dVdUWDNNbmJtS0FWZ0lycjNkc1pPb2xSNWwxei1LbUtUclRTdlMtTkRYQno4VnBmUU4zZFBGS09wR3Q5UE9ZbWlYMlFuOWVBRHF2XzZnTFlyVm53elotYlNSOVBGc19ZdGhvUVV3ZkVmMGVBM1hnT0lOMGNvOGN2SjE?oc=5","date":"2026-02-12","type":"pipeline","source":"Yicai Global","summary":"Italy’s Recordati Is Exiting China After Poor Sales of Rare Disease Drugs, Insider Says - Yicai Global","headline":"Italy’s Recordati Is Exiting China After Poor Sales of Rare Disease Drugs, Insider Says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxQR1JHRnYwRk11Yi02ZGdBS1lLZmtPQWN2Q3NLZldJdmlUM0ZWRGs2STQwNzROVkZRcm8wNGhHSVVJWVlDeUNMOEkyN2NDTTQwcjlXUXdYRlZOQlRaSXVJa2MxWUhVVmFsOXZCQnJ1TW1rTHFXS3NzTzBzQUw4ZExKQTVsTk5nMVBhOEJMTmplV013STk3MmdWa0c4bTZVYm16TzB2TkRHWGVIT0NxM1Q2VC1HVjh6UGU5eW0zeXRTY2FsYTRQV1JHOWNXUENobWl4MEpTUWNEVW83MklGX1JNRHp1NVVXRjlUMlo3dWZOSEwyMzVrc1NIbHFYVmUwX0xRVUlSdkZRLWN5SnFzcmNjU2taUXE2ckcyOTNMa1M5UmFuTkZGeGttNkhjNkpOT3l2N2NWNzFuX00yamU5OWRnS3J2eHlKTXk4R1VkUmc2WFlnYUdMdkNhNloxcUJsU3VHV1ZR?oc=5","date":"2026-02-06","type":"deal","source":"Mondaq","summary":"United States - Goodwin Advises Moderna On Strategic Collaboration With Recordati To Globally Commercialize Investigational Propionic Acidemia Therapeutic (MRNA-3927) For $50 Million Upfront And Up To","headline":"United States - Goodwin Advises Moderna On Strategic Collaboration With Recordati To Globally Commercialize Investigatio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb3pQRHJ1dkIyUDdDSVl2bjdjdE13ZGpURmdIamxHa2RZaTduLUhveEhCY3loX1MyQlg3UDZBdG5WbjZsOF8zMDNKSko5X01lN0tPdWZOdVJHYk80YjFiS3YyMlllQmhfcVNfSmJaMGdUSmFRTWs0X1hwcEFrUUhKY1RCeHFKMnVuc3lJZWdtLXllWTFTV0hid0dFV0pmOUxZYnl6dnhzRk8?oc=5","date":"2026-02-02","type":"deal","source":"Manufacturing Chemist","summary":"Moderna partners with Recordati to commercialise propionic acidemia mRNA therapy - Manufacturing Chemist","headline":"Moderna partners with Recordati to commercialise propionic acidemia mRNA therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxQLWFwNW5scGZCN0RTSGVjcHVwUktKYTctZDlvMFF0MG15V2JwSWVwdDlPc2Jjbk51ZHhNRTh1a243elJwS2cxcGJZM1VBckY5TEVIMTkwWFdGTzVOUlp3R3VBU2EzdGlNeW5DYllfWldRVFVVcjdTR3lrVi1QZk5XdXRxMDRsVnBIMXpWYnBDejBtQUl4YWdiQzNGSGxfMXFuZFJMcEVDRGhFNURTdk1Sc3N6TUU0TzNrSGppYnh0Z3Zwc1QxTzhsWTBkcUFqSE9MeEFKUVZNdjVmTGhxWGlZTXp2VTVlN1pNemdtMGlNeWdBQjduRmdLbHhKUmx0SzlxcXBhaElGVFl2LXhqUUFxUnNjd3hCZHJQV0RucUY3R28zTGliWmpF?oc=5","date":"2026-01-29","type":"deal","source":"The Des Moines Register","summary":"Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927) - The Des Moines Register","headline":"Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQekZ0SjVuZGRESl83MDBXZHV0d1JGTVAtcVRGUlRncFlCNXBWVzFNSGZoZ0R1NER1dUpkVUN0eVNiMy1aMFQzS09ZalBFOTAtRl9MX3J2UzN6VW5VQU1FTlF2MFdHbzl3Ry0xMV9HbmdwREhmeVJicEVYNElKZWhUYWNHVzJkaFVtUGQw?oc=5","date":"2026-01-27","type":"pipeline","source":"PharmaTimes","summary":"Gedeon Richter UK takes over UK rights to cariprazine - PharmaTimes","headline":"Gedeon Richter UK takes over UK rights to cariprazine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOUktUeWRudnlKdWw5V2EybjRQZ1o1M3BjMXY1UnBZZ2pobDZtLU1CY25xQ0MwanQzSjFNczhjMjhERUt5T3BqckN0REUteHM5bjBXdVNvSnZKd25nSzZVS25pbUVVVHk3UjdVV0FFRDhjaF9RWl9DY1haVEMzRlh1dExxMVNrQ014MWFKeHRSMWRWRzlmbkJkNUlkVVYtWEgxWDNuSzMxckFfWDFxOEc1ellIM2JfSlhlVFR6S3UyS195UGk5LVNvVDZZSlAxb2JpdW01aENuYVNkUDNlNGZV?oc=5","date":"2025-06-05","type":"pipeline","source":"Reuters","summary":"Italy's Chiesi Group plans acquisitions to boost sales to 6 billion euros by 2030 - Reuters","headline":"Italy's Chiesi Group plans acquisitions to boost sales to 6 billion euros by 2030","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}